| ELAN CORP., PLC (NY:ELN) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $6.97 | 52 Week High | $8.59 | ||
| Open | $7.10 | 52 Week Low | $4.61 | ||
| Day High | $7.15 | P/E | N/A | ||
| Day Low | $6.95 | EPS | $0.00 | ||
| Volume | 2,216,248 | ||||
| More ELN Info: Chart SEC Filings Profile Historical Options | |||||
Elan Corporation, plc operates as a neuroscience-based biotechnology company primarily in Ireland and the United States. It operates through two segments, Biopharmaceuticals and Elan Drug Technologies. The Biopharmaceuticals segment engages in the research, development, and commercialization of therapies in the areas of autoimmune diseases and neurodegenerative diseases. The EDT segment engages in development, scale-up, and manufacture of drug optimization technologies, including NanoCrystal technology that involves reducing crystalline drug to particles under 400 ...more
G. Kelly Martin - CEO, President
Kryan McLaughlin - Chairman
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| BIIB | 15 | JNJ | 11 |
| ACOR | 9 | TTHI | 6 |
| ELAN | 5 | AMGN | 4 |
| BMY | 4 | FCX | 3 |
| PTV | 3 | FCX | 3 |
| SLM | 3 | IRBT | 3 |
No comments are currently available.
on Aug 3, 2008
at 08:28 PM Investigate what? Their pipeline has a clog in it..namely killing people. the stock should trade down. if you think they have long term prospects..buy this stock then. don't blame the market..free market capitalism is the best path to prosperity!
Article: Goldman Sachs Removes Elan Corp. plc (ELN) from its Conviction Buy List
on Aug 3, 2008
at 08:27 PM OUCH So much for being a buyer at 19 eh?
Article: Goldman Sachs Removes Elan Corp. plc (ELN) from its Conviction Buy List
on Aug 1, 2008
at 07:13 PM gumby's info wrong gumby, we are not told to not take Tysabri if we have been on Avonex, copaxone, etc. We are told to be off them for 30 days before starting Tysabri
Article: Biogen Idec (BIIB) Sinks on TYSABRI PML Fears, Wall Street Comments...
on Aug 1, 2008
at 12:08 PM I Filed Complaint at SEC.GOV I just filed an electronic complaint at www. SEC .GOV stating that the steep drop of 25% in Biogen Idec was unjustified and must be restored back to a higher price.
Article: Biogen Idec (BIIB) Sinks on TYSABRI PML Fears, Wall Street Comments...
on Aug 1, 2008
at 12:06 PM brettze@aol.com Dont believe the analysts that patients will be moved off Tysabri. It was already known that any patients previously been on older MS medicines like Avonex and Rebif should not move to Tysabri. Tysabri is for new MS patients who was never on older MS medicines. Do not be suckered into selling Bigoen by analysts. Analysts know nothing about Biogen Idec.
Article: Biogen Idec (BIIB) Sinks on TYSABRI PML Fears, Wall Street Comments...